oxybutynin has been researched along with Nocturnal Enuresis in 21 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Nocturnal Enuresis: Involuntary discharge of URINE during sleep at night after expected age of completed development of urinary control.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the efficacy of desmopressin plus oxybutynin and compare two starting dosages of desmopressin (120 and 240 µg) in a randomized, double-blinded, placebo-controlled trial for children with monosymptomatic nocturnal enuresis (MNE) resistant to desmopressin." | 9.16 | Desmopressin and oxybutynin in monosymptomatic nocturnal enuresis: a randomized, double-blind, placebo-controlled trial and an assessment of predictive factors. ( Del Gado, R; Iossa, AC; Montaldo, P; Narciso, V; Rea, M; Tafuro, L, 2012) |
| "To evaluate the efficacy of two drugs: the anticholinergic agent oxybutynin (Ditropan) and the calcium channel blocker verapamil (Isoptin) in the management of nocturnal enuresis in patients with orthotopic ileal reservoirs." | 9.13 | Clinical and urodynamic efficacy of oxybutynin and verapamil in the treatment of nocturnal enuresis after formation of orthotopic ileal neobladders. A prospective, randomized, crossover study. ( El-Bahnasawy, MS; Gomha, MA; Nabeeh, A; Shaaban, H, 2008) |
| "Combination therapy (CT) (desmopressin plus oxybutynin) has been considered for the treatment of monosymptomatic nocturnal enuresis (MNE)." | 8.31 | Combination therapy (desmopressin plus oxybutynin) improves the response rate compared with desmopressin alone in patients with monosymptomatic nocturnal enuresis and nocturnal polyuria and absence of constipation predict the response to this treatment. ( Capalbo, D; Di Sessa, A; Esposito, C; Grella, C; Guarino, S; Marzuillo, P; Miraglia Del Giudice, E; Papparella, A, 2023) |
| "Enuresis is identified as voluntary or involuntary leakage of urine for at least three consecutive months in the daytime and/or nighttime on clothes for children older than five." | 5.62 | Desmopressin versus desmopressin + oxybutynin in the treatment of children with nocturnal enuresis. ( Çakıroğlu, B; Gözüküçük, A; Kılıç, M, 2021) |
| " Desmopressin in combination with a fixed dose anticholinergic has been shown to be useful in individuals who fail desmopressin monotherapy, but still fails to achieve success rates greater than 60%." | 5.43 | Evaluating use of higher dose oxybutynin in combination with desmopressin for refractory nocturnal enuresis. ( Berkenwald, A; Ellsworth, P; Pires, J, 2016) |
| "To compare the results of the standard urotherapy alone and associated with pelvic floor muscle training alone, and in combination with oxybutynin in treatment of nonmonosymptomatic nocturnal enuresis." | 5.30 | Pelvic floor muscle training alone or in combination with oxybutynin in treatment of nonmonosymptomatic enuresis. A randomized controlled trial with 2-year follow up. ( Campos, RM; D'Ancona, CAL; Glazer, HI; Hacad, CR; Lopes, MHBM; Lúcio, AC; Perissinotto, MCR, 2019) |
| "To assess the efficacy of desmopressin plus oxybutynin and compare two starting dosages of desmopressin (120 and 240 µg) in a randomized, double-blinded, placebo-controlled trial for children with monosymptomatic nocturnal enuresis (MNE) resistant to desmopressin." | 5.16 | Desmopressin and oxybutynin in monosymptomatic nocturnal enuresis: a randomized, double-blind, placebo-controlled trial and an assessment of predictive factors. ( Del Gado, R; Iossa, AC; Montaldo, P; Narciso, V; Rea, M; Tafuro, L, 2012) |
| "To evaluate the efficacy of two drugs: the anticholinergic agent oxybutynin (Ditropan) and the calcium channel blocker verapamil (Isoptin) in the management of nocturnal enuresis in patients with orthotopic ileal reservoirs." | 5.13 | Clinical and urodynamic efficacy of oxybutynin and verapamil in the treatment of nocturnal enuresis after formation of orthotopic ileal neobladders. A prospective, randomized, crossover study. ( El-Bahnasawy, MS; Gomha, MA; Nabeeh, A; Shaaban, H, 2008) |
| "We assessed prospectively the efficacy of holding exercises and/or antimuscarinics (oxybutynin chloride and placebo) for increasing maximum voided volume in prepubertal children with monosymptomatic nocturnal enuresis." | 5.12 | Do holding exercises or antimuscarinics increase maximum voided volume in monosymptomatic nocturnal enuresis? A randomized controlled trial in children. ( Bael, A; Bernaerts, K; Hirche, H; Lax, H; Van Dessel, E; van Gool, JD; Van Hoeck, KJ; Van Renthergem, D; Vandermaelen, V, 2007) |
| "Combination therapy (CT) (desmopressin plus oxybutynin) has been considered for the treatment of monosymptomatic nocturnal enuresis (MNE)." | 4.31 | Combination therapy (desmopressin plus oxybutynin) improves the response rate compared with desmopressin alone in patients with monosymptomatic nocturnal enuresis and nocturnal polyuria and absence of constipation predict the response to this treatment. ( Capalbo, D; Di Sessa, A; Esposito, C; Grella, C; Guarino, S; Marzuillo, P; Miraglia Del Giudice, E; Papparella, A, 2023) |
| "The patients who had lower urinary tract symptoms (LUTS) were classified as nonmonosymptomatic NE (NMNE)." | 2.87 | The Relationship Between Nocturnal Enuresis and Spina Bifida Occulta: A Prospective Controlled Trial. ( Bayar, G; Kilinc, MF; Sariogullari, U; Yavuz, A, 2018) |
| "Bedwetting (nocturnal enuresis) is not uncommon in childhood but it can have a profound effect on children and their families." | 2.44 | Nocturnal enuresis in children. ( Dobson, P; Weaver, A, 2007) |
| "Enuresis is identified as voluntary or involuntary leakage of urine for at least three consecutive months in the daytime and/or nighttime on clothes for children older than five." | 1.62 | Desmopressin versus desmopressin + oxybutynin in the treatment of children with nocturnal enuresis. ( Çakıroğlu, B; Gözüküçük, A; Kılıç, M, 2021) |
| " Desmopressin in combination with a fixed dose anticholinergic has been shown to be useful in individuals who fail desmopressin monotherapy, but still fails to achieve success rates greater than 60%." | 1.43 | Evaluating use of higher dose oxybutynin in combination with desmopressin for refractory nocturnal enuresis. ( Berkenwald, A; Ellsworth, P; Pires, J, 2016) |
| " Taking domestic usage by age group into account, there is a disproportionately higher number of CNS adverse event cases reported in pediatric patients as compared with adult patients." | 1.35 | Spectrum of central anticholinergic adverse effects associated with oxybutynin: comparison of pediatric and adult cases. ( Gish, P; Johann-Liang, R; Mosholder, AD; Truffa, M, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (33.33) | 29.6817 |
| 2010's | 11 (52.38) | 24.3611 |
| 2020's | 3 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Moretti, E | 1 |
| Barbosa, L | 1 |
| da Silva, IB | 1 |
| de Lima, AMJ | 1 |
| Lemos, A | 1 |
| Capalbo, D | 1 |
| Guarino, S | 1 |
| Di Sessa, A | 1 |
| Esposito, C | 1 |
| Grella, C | 1 |
| Papparella, A | 1 |
| Miraglia Del Giudice, E | 1 |
| Marzuillo, P | 1 |
| Gözüküçük, A | 1 |
| Kılıç, M | 1 |
| Çakıroğlu, B | 1 |
| Yavuz, A | 1 |
| Bayar, G | 1 |
| Kilinc, MF | 1 |
| Sariogullari, U | 1 |
| Campos, RM | 1 |
| Lúcio, AC | 1 |
| Lopes, MHBM | 1 |
| Hacad, CR | 1 |
| Perissinotto, MCR | 1 |
| Glazer, HI | 1 |
| D'Ancona, CAL | 1 |
| Rittig, N | 1 |
| Hagstroem, S | 1 |
| Mahler, B | 1 |
| Kamperis, K | 1 |
| Siggaard, C | 1 |
| Mikkelsen, MM | 1 |
| Bower, WF | 1 |
| Djurhuus, JC | 1 |
| Rittig, S | 1 |
| Ellsworth, PI | 1 |
| Berkenwald, A | 1 |
| Pires, J | 1 |
| Ellsworth, P | 1 |
| Saldano, DD | 1 |
| Chaviano, AH | 1 |
| Maizels, M | 1 |
| Azhir, A | 1 |
| Gheissari, A | 1 |
| Fragzadegan, Z | 1 |
| Adebi, A | 1 |
| El-Bahnasawy, MS | 1 |
| Shaaban, H | 1 |
| Gomha, MA | 1 |
| Nabeeh, A | 1 |
| Gish, P | 1 |
| Mosholder, AD | 1 |
| Truffa, M | 1 |
| Johann-Liang, R | 1 |
| Boetzkes, S | 1 |
| Van Hoeck, K | 1 |
| Verbrugghe, W | 1 |
| Ramet, J | 1 |
| Wojciechowski, M | 1 |
| Jorens, PG | 1 |
| Yucel, S | 1 |
| Kol, A | 1 |
| Guntekin, E | 1 |
| Baykara, M | 1 |
| Wiener, JS | 1 |
| Friedman, BC | 1 |
| Friedman, B | 1 |
| Goldman, RD | 1 |
| Deshpande, AV | 1 |
| Caldwell, PH | 1 |
| Montaldo, P | 1 |
| Tafuro, L | 1 |
| Rea, M | 1 |
| Narciso, V | 1 |
| Iossa, AC | 1 |
| Del Gado, R | 1 |
| Zaffanello, M | 1 |
| Giacomello, L | 1 |
| Brugnara, M | 1 |
| Fanos, V | 1 |
| Van Hoeck, KJ | 1 |
| Bael, A | 1 |
| Van Dessel, E | 1 |
| Van Renthergem, D | 1 |
| Bernaerts, K | 1 |
| Vandermaelen, V | 1 |
| Lax, H | 1 |
| Hirche, H | 1 |
| van Gool, JD | 1 |
| Weaver, A | 1 |
| Dobson, P | 1 |
4 reviews available for oxybutynin and Nocturnal Enuresis
| Article | Year |
|---|---|
What do cochrane systematic reviews say about interventions for enuresis in children and adolescents? An overview of systematic reviews.
Topics: Adolescent; Child; Deamino Arginine Vasopressin; Enuresis; Humans; Imipramine; Nocturnal Enuresis; S | 2022 |
Medical management of nocturnal enuresis.
Topics: Algorithms; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricyclic; Antidiuretic | 2012 |
Therapeutic options in childhood nocturnal enuresis.
Topics: Antidiuretic Agents; Arginine Vasopressin; Behavior Therapy; Child; Child, Preschool; Deamino Argini | 2007 |
Nocturnal enuresis in children.
Topics: Antidiuretic Agents; Causality; Child; Deamino Arginine Vasopressin; Health Education; Humans; Mande | 2007 |
7 trials available for oxybutynin and Nocturnal Enuresis
| Article | Year |
|---|---|
The Relationship Between Nocturnal Enuresis and Spina Bifida Occulta: A Prospective Controlled Trial.
Topics: Antidiuretic Agents; Child; Deamino Arginine Vasopressin; Female; Humans; Lower Urinary Tract Sympto | 2018 |
Pelvic floor muscle training alone or in combination with oxybutynin in treatment of nonmonosymptomatic enuresis. A randomized controlled trial with 2-year follow up.
Topics: Brazil; Child; Child, Preschool; Combined Modality Therapy; Exercise Therapy; Female; Humans; Male; | 2019 |
New treatment protocol for primary nocturnal enuresis in children according to ultrasound bladder measurements.
Topics: Antidiuretic Agents; Child; Clinical Protocols; Combined Modality Therapy; Deamino Arginine Vasopres | 2008 |
Clinical and urodynamic efficacy of oxybutynin and verapamil in the treatment of nocturnal enuresis after formation of orthotopic ileal neobladders. A prospective, randomized, crossover study.
Topics: Adult; Calcium Channel Blockers; Cholinergic Antagonists; Colonic Pouches; Cross-Over Studies; Cyste | 2008 |
Anticholinergics do not improve cure rate of alarm treatment of monosymptomatic nocturnal enuresis.
Topics: Adolescent; Child; Cholinergic Antagonists; Clinical Alarms; Combined Modality Therapy; Female; Huma | 2011 |
Desmopressin and oxybutynin in monosymptomatic nocturnal enuresis: a randomized, double-blind, placebo-controlled trial and an assessment of predictive factors.
Topics: Adolescent; Antidiuretic Agents; Child; Deamino Arginine Vasopressin; Double-Blind Method; Female; H | 2012 |
Do holding exercises or antimuscarinics increase maximum voided volume in monosymptomatic nocturnal enuresis? A randomized controlled trial in children.
Topics: Behavior Therapy; Child; Child, Preschool; Conditioning, Classical; Female; Follow-Up Studies; Human | 2007 |
10 other studies available for oxybutynin and Nocturnal Enuresis
| Article | Year |
|---|---|
Combination therapy (desmopressin plus oxybutynin) improves the response rate compared with desmopressin alone in patients with monosymptomatic nocturnal enuresis and nocturnal polyuria and absence of constipation predict the response to this treatment.
Topics: Child; Constipation; Deamino Arginine Vasopressin; Female; Humans; Male; Nocturnal Enuresis; Polyuri | 2023 |
Desmopressin versus desmopressin + oxybutynin in the treatment of children with nocturnal enuresis.
Topics: Antidiuretic Agents; Child; Deamino Arginine Vasopressin; Enuresis; Female; Humans; Male; Mandelic A | 2021 |
Outcome of a standardized approach to childhood urinary symptoms-long-term follow-up of 720 patients.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Antidiuretic Agents; Biofeedback, Psychology; Child; Child | 2014 |
Response to Commentary re 'Evaluating use of higher dose oxybutynin in combination with desmopressin for refractory nocturnal enuresis'.
Topics: Antidiuretic Agents; Deamino Arginine Vasopressin; Enuresis; Humans; Mandelic Acids; Nocturnal Enure | 2016 |
Evaluating use of higher dose oxybutynin in combination with desmopressin for refractory nocturnal enuresis.
Topics: Adolescent; Antidiuretic Agents; Attention Deficit Disorder with Hyperactivity; Child; Deamino Argin | 2016 |
Sustainability of remission of pediatric primary nocturnal enuresis--comparison of remission using Try for Dry vs. non-Try for Dry treatment plans.
Topics: Adolescent; Algorithms; Antidiuretic Agents; Child; Combined Modality Therapy; Constipation; Deamino | 2008 |
Spectrum of central anticholinergic adverse effects associated with oxybutynin: comparison of pediatric and adult cases.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Central Nervous System; Chi | 2009 |
Two unusual pediatric cases of dilutional hyponatremia.
Topics: Antidiuretic Agents; Child; Cholinergic Antagonists; Deamino Arginine Vasopressin; Drug Therapy, Com | 2010 |
Editorial comment. Anticholinergics do not improve cure rate of alarm treatment of monosymptomatic nocturnal enuresis.
Topics: Adolescent; Child; Cholinergic Antagonists; Clinical Alarms; Combined Modality Therapy; Humans; Mand | 2011 |
Oxybutynin for treatment of nocturnal enuresis in children.
Topics: Child; Humans; Mandelic Acids; Muscarinic Antagonists; Nocturnal Enuresis | 2011 |